Short communication · 4 Aug 2026
Conference abstractPublished 30 Nov 2015
Efficacy and safety of tenecteplase with standard anticoagulation therapy versus standard anticoagulation therapy alone for sub massive or intermediate-risk pulmonary embolism: A metaanalysis
St. Luke’s Medical Center, Philippines
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objectives: To determine the efficacy and safety of tenecteplase with anticoagulation versus anticoagulation alone in patients with intermediate-risk Pulmonary Embolism (PE) in reducing all-cause mortality, respiratory distress requiring Mechanical Ventilation (MV), recurrence of PE and major bleeding episodes. Design: Meta-analysis including three RCTs. Setting: Studies included were performed in Italian, German, and American medical centers. Participants: Inclusion criteria: adult patients diagnosed with PE with RV dysfunction on echocardiogram or CT scan with stable hemodynamic status. Exclusion criteria: hemodynamic instability, history of bleeding, and contraindication to anticoagulants. Interventions: Weight-based tenecteplase with anticoagulation versus anticoagulation alone. Main Outcome Measures: Efficacy outcome measures: reduction in all-cause mortality, respiratory distress requiring MV and recurrence of PE; Safety outcome parameter: major bleeding episodes. Results: There is no statistically significant difference for death from any cause (Z=0.89, pvalue0.37), however, there is a trend favoring tenecteplase group (OR0.65, CI0.26-1.66). There is also no statistically significant difference for reduction in respiratory distress requiring MV and recurrence of PE, but there is a trend favoring tenecteplase group. In terms of major bleeding, there is a statistically significant difference, favoring placebo (OR4.91, CI2.68-8.97). Conclusion: There is a trend favoring tenecteplase in intermediate-risk PE in terms of all-cause mortality, respiratory distress requiring mechanical ventilation and recurrence of PE, however, with increased rate of major bleeding.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical and Experimental Cardiology.
Conference abstract · 15 Jun 2026
Speckle Tracking Echocardiography for Early Identification of Chemotherapy-Induced Cardiotoxicity
Conference abstract · 15 Jun 2026
Coronary CT Angiography as a First-Line Diagnostic Tool for Stable Chest Pain: Clinical Outcomes from a Multicenter Study
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical and Experimental Cardiology
- SubjectCardiology
- BylineArticles whose byline prints “Lea Arceli G Porciuncula”
- BylineArticles whose byline prints “Evelyn A Esposo”
